GMED Globus Medical, Inc. Class A Common Stock

NYSE · Health Care · Ver em SEC EDGAR ↗
$88,24
Preço · Ago 19, 2026
Fundamentais a partir de Ago 6, 2026

Sobre Globus Medical, Inc. Class A Common Stock Visão geral da empresa da Wikipedia

Globus Medical, Inc. is a publicly traded orthopedic medical device company headquartered in Audubon, Pennsylvania, United States. Globus is focused on the design, development, and commercialization of products that enable surgeons to promote healing in patients with musculoskeletal disorders.

Ler mais

Globus Medical, Inc. is a publicly traded orthopedic medical device company headquartered in Audubon, Pennsylvania, United States. Globus is focused on the design, development, and commercialization of products that enable surgeons to promote healing in patients with musculoskeletal disorders.

Products

Globus develops, manufactures, and markets orthopedic implants including spine, trauma, and artificial joints.

Globus Medical makes the ExcelsiusGPS surgical robotic system for spine surgery. The robot is used for transpedicular drilling and screw placement. In November 2024, the company launched its ExcesiusHub, an advanced surgical navigation system for robotic surgical procedures.

The ADIRA XLIF Plate System aids in enhancing lateral spine surgery procedures.

Acquisitions

In January 2014, Globus Medical acquired Excelsius Surgical. The Excelsius system is designed to integrate intra-operative digital imaging with a robotic surgery device to hold patients in place during surgeries "with sub-millimeter accuracy". In October of that year, the company acquired allograft tissue processor Transplant Technologies of Texas, Ltd. (TTOT). TTOT provides human tissue products, including bone allografts, biomaterials, and soft tissue products for spine, orthopedics, sports medicine, dental, and wound care markets.

In February 2015, Globus Medical acquired Branch Medical Group, a third-party manufacturer of high-precision medical devices.

In July 2016, Globus Medical acquired Alphatec Holdings, an international operations and distribution channel, for $80 million. As part of the transaction, Globus has agreed to provide Alphatec a five-year senior secured credit facility of up to $30 million.

In September 2018, Globus Medical acquired Nemaris, developers of Surgimap, a pre-operative planning software for spinal surgeons.

In August 2019, Globus Medical acquired privately owned StelKast, manufacturer of implants and instruments for hip and knee replacement.

In February 2023, Globus Medical acquired NuVasive in an all-stock deal valued at $3.1 billion.

Controversies

In August 2007 Globus Medical settled a lawsuit initially filed by Synthes in 2004 over alleged stolen trade secrets. Former Synthes employees, who then worked for Globus, were accused of stealing 2300 electronic files containing blueprints for Synthes' products, safety-testing plans, and verbatim 510(k) filing documents. Globus paid Synthes $13.5 million and did not admit any wrongdoing.

In 2011, Synthes filed a second lawsuit against Globus Medical for infringing three patents, "asking the court to force the defendant to destroy its allegedly infringing products." Orthopedic Design & Technology Magazine reports that, "There was no finding of willful infringement in this lawsuit." A $16 million monetary damage was paid by Globus Medical in 2013.

Fonte: Wikipedia (Inglês), CC BY-SA 4.0 · Ver na Wikipedia ↗

Wikidata ↗

GMED Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas

Preço
$88.24
Capitalização de Mercado
P/E (TTM)
22.3
EPS (TTM)
$3.92
Receita (TTM)
$2.94B
Rendimento div.
ROE
12.1%
Dívida/Capital
Intervalo 52 Semanas
$54 – $101

GMED Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização

Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS

Receita e Lucro Líquido $2.94B
10-point trend, +421.1%
2016-12-31 2025-12-31
EPS $3.92
10-point trend, +263.0%
2016-12-31 2025-12-31
Fluxo de caixa livre $589M
9-point trend, +349.5%
2016-12-31 2025-12-31
Margens 18.3%
7-point trend, -14.5%
2016-12-31 2023-12-31

Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?

Métrica
Tendência de 5 anos
GMED
Mediana de Pares
P/E (TTM)
5-point trend, -55.6%
22.3
27.5

Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC

Métrica
Tendência de 5 anos
GMED
Mediana de Pares
Operating Margin (Margem Operacional)
5-point trend, +15.7%
16.3%
Net Profit Margin (Margem de Lucro Líquido)
5-point trend, +41.2%
18.3%
9.8%
ROA
5-point trend, +60.0%
10.2%
5.1%
ROE
5-point trend, +73.3%
12.1%
8.6%
ROIC
5-point trend, +55.2%
9.3%

Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial

Métrica
Tendência de 5 anos
GMED
Mediana de Pares
Current Ratio (Índice de liquidez corrente)
5-point trend, -37.3%
4.3
2.7
Quick Ratio (Índice de Liquidez Seca)
5-point trend, +111.4%
2.5

Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos

Métrica
Tendência de 5 anos
GMED
Mediana de Pares
Revenue YoY (Receita Ano a Ano)
5-point trend, +206.7%
16.7%
Revenue CAGR 3Y (CAGR Receita 3A)
5-point trend, +206.7%
42.2%
Revenue CAGR 5Y (CAGR Receita 5A)
5-point trend, +206.7%
30.1%
EPS YoY
5-point trend, +172.2%
422.7%
Net Income YoY (Lucro Líquido Ano a Ano)
5-point trend, +260.5%
422.3%

Métricas por Ação EPS, valor patrimonial por ação, fluxo de caixa por ação, dividendo por ação

Métrica
Tendência de 5 anos
GMED
Mediana de Pares
EPS (Diluted) (EPS (Diluído))
5-point trend, +172.2%
$3.92

Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber

Métrica
Tendência de 5 anos
GMED
Mediana de Pares

GMED Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta

COMPRA 23 analistas
  • Compra forte 4 17,4%
  • Compra 12 52,2%
  • Manter 7 30,4%
  • Venda 0 0,0%
  • Venda forte 0 0,0%

Preço-alvo de 12 meses

13 analistas · 2026-08-15
Alvo mediano $100.00 +13,3%
Alvo médio $103.23 +17,0%

Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados

Surpresa Média
0.15%
Período EPS Actual EPS est. Surpresa
30 de Junho de 2026 $1.34 $1.12 0.22%
31 de Março de 2026 $1.12 $0.94 0.18%
31 de Dezembro de 2025 $1.28 $1.17 0.11%
30 de Setembro de 2025 $1.18 $0.80 0.38%
30 de Junho de 2025 $0.86 $0.77 0.09%
31 de Março de 2025 $0.68 $0.76 -0.08%

Comparação de pares (subindústria GICS) Métricas chave vs pares do setor

Ticker Capitalização de Mercado P/E Receita YoY Margem Líquida ROE Margem Bruta
GMED 22.3 16.7% 18.3% 12.1%
RMD $28.11B 18.7 9.8% 26.9% 23.6% 61.1%
ZBH $28.66B 25.3 7.2% 8.6% 5.6%
BAX $13.05B -10.2 5.7% -8.5% -14.6% 30.0%
PEN $12.20B 68.8 17.5% 12.7% 13.1% 67.1%
GKOS $6.49B -34.4 32.3% -37.0% -26.4% 55.7%
PODD $20.01B 81.7 30.7% 9.1% 16.6% 71.6%
TFX -6.0 17.2% -45.5% -24.6% 56.2%
NVST $3.56B 77.5 8.3% 1.7% 1.5% 54.7%
ITGR $2.69B 27.1 8.0% 5.5% 6.0% 27.0%
ABT $250.18B 33.7 5.7% 14.7% 13.1%

Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa

Demonstração de Resultados 16
Dados anuais de Demonstração de Resultados para GMED
Métrica Tendência 202520242023202220212020201920182017201620152014
Revenue 12-point trend, +519.5% $2.94B $2.52B $1.57B $1.02B $958M $789M $785M $713M $636M $564M $545M $474M
Cost of Revenue 12-point trend, +764.7% $958M $1.04B $548M $264M $239M $217M $180M $159M $150M $135M $132M $111M
Gross Profit 10-point trend, +180.6% · · $1.02B $759M $719M $572M $605M $554M $486M $429M $412M $364M
R&D Expense 12-point trend, +372.5% $147M $164M $124M $73M $97M $85M $60M $55M $44M $45M $36M $31M
SG&A Expense 12-point trend, +524.8% $1.18B $981M $644M $432M $408M $355M $355M $312M $268M $222M $210M $189M
Operating Expenses 10-point trend, +293.9% · · $887M $531M $547M $460M $433M $384M $324M $275M $240M $225M
Operating Income 12-point trend, +246.8% $480M $166M $133M $228M $172M $111M $172M $169M $162M $154M $172M $138M
Other Non-op 12-point trend, +1118.9% $3M $2M $-2M $2M $8M $14M $18M $19M $8M $3M $583.0K $280.0K
Pretax Income 12-point trend, +336.4% $605M $121M $165M $243M $180M $126M $190M $189M $170M $157M $173M $139M
Income Tax 12-point trend, +45.6% $67M $18M $43M $53M $31M $24M $35M $32M $63M $53M $60M $46M
Net Income 12-point trend, +481.6% $538M $103M $123M $190M $149M $102M $155M $156M $107M $104M $113M $92M
EPS (Basic) 12-point trend, +306.1% $3.98 $0.76 $1.09 $1.89 $1.48 $1.04 $1.57 $1.60 $1.12 $1.09 $1.19 $0.98
EPS (Diluted) 12-point trend, +304.1% $3.92 $0.75 $1.07 $1.85 $1.44 $1.01 $1.52 $1.54 $1.10 $1.08 $1.17 $0.97
Shares (Basic) 12-point trend, +43.5% 135,215,000 135,726,000 113,087,000 100,469,000 100,734,000 98,580,000 99,150,000 97,884,000 96,243,000 95,647,000 95,046,000 94,227,000
Shares (Diluted) 12-point trend, +43.6% 137,056,000 137,863,000 114,630,000 102,643,000 103,623,000 100,971,000 101,998,000 101,316,000 97,887,000 96,432,000 96,073,000 95,457,000
EBITDA 11-point trend, +372.6% $757M $420M $278M · $242M $174M $225M $211M $204M $193M $196M $160M
Balanço Patrimonial 26
Dados anuais de Balanço Patrimonial para GMED
Métrica Tendência 202520242023202220212020201920182017201620152014
Cash & Equivalents 8-point trend, +539.6% $526M $784M · · · · $195M $140M $119M $67M $58M $82M
Short-term Investments 11-point trend, -78.8% $31M $106M $50M $296M $250M $187M · $200M $255M $223M $221M $146M
Receivables 12-point trend, +800.1% $679M $558M $503M $213M $164M $142M $154M $137M $117M $92M $78M $75M
Inventory 12-point trend, +734.9% $759M $659M $848M $299M $237M $229M $196M $131M $108M $113M $105M $91M
Prepaid Expense 12-point trend, +1039.4% $65M $50M $45M $21M $18M $18M $17M $15M $11M $15M $7M $6M
Current Assets 12-point trend, +352.2% $2.13B $2.18B $1.92B $983M $865M $822M $687M $631M $620M $514M $545M $470M
PP&E (Net) 12-point trend, +712.5% $564M $562M $587M $244M $221M $217M $200M $172M $143M $124M $115M $69M
PP&E (Gross) 12-point trend, +575.2% $1.27B $1.11B $1.01B $587M $527M $493M $444M $389M $335M $291M $254M $188M
Accum. Depreciation 12-point trend, +494.7% $705M $546M $426M $343M $306M $276M $244M $217M $192M $167M $139M $119M
Goodwill 12-point trend, +2597.6% $1.44B $1.43B $1.43B $197M $180M $157M $129M $124M $124M $106M $92M $53M
Intangibles 12-point trend, +2057.8% $745M $795M $925M $64M $69M $87M $79M $87M $79M $62M $33M $35M
Other Non-current Assets 12-point trend, +7980.1% $79M $75M $79M $37M $36M $32M $22M $10M $8M $928.0K $590.0K $975.0K
Total Assets 12-point trend, +653.7% $5.30B $5.25B $5.09B $2.08B $1.96B $1.68B $1.53B $1.30B $1.08B $928M $834M $704M
Accounts Payable 12-point trend, +521.6% $99M $75M $57M $36M $22M $18M $25M $26M $25M $17M $16M $16M
Accrued Liabilities 12-point trend, +442.4% $334M $261M $240M $92M $91M $78M $63M $60M $53M $46M $54M $61M
Current Liabilities 12-point trend, +457.5% $498M $856M $392M $159M $140M $121M $111M $96M $93M $80M $83M $89M
Capital Leases 7-point trend, +8999.6% $104M $84M $91M $3M $3M $3M $1M · · · · ·
Deferred Tax 11-point trend, +362.4% · $24M $84M $2M $4M $6M $6M $8M $11M $8M $13M $5M
Other Non-current Liabilities 12-point trend, +542.9% $21M $22M $25M $10M $13M $15M $9M $8M $2M $2M $2M $3M
Total Liabilities 12-point trend, +517.7% $730M $1.07B $1.09B $230M $216M $173M $130M $115M $111M $96M $119M $118M
Paid-in Capital 12-point trend, +1708.8% $3.17B $3.03B $2.87B $631M $554M $457M $357M $300M $238M $212M $193M $175M
Retained Earnings 12-point trend, +237.1% $1.39B $1.15B $1.14B $1.24B $1.19B $1.05B $1.05B $893M $736M $629M $525M $412M
AOCI 12-point trend, +1026.1% $15M $-7M $-10M $-25M $-7M $4M $-3M $-7M $-7M $-9M $-2M $-2M
Stockholders' Equity 12-point trend, +681.1% $4.57B $4.18B $4.00B $1.85B $1.74B $1.51B $1.40B $1.19B $968M $832M $715M $585M
Liabilities + Equity 12-point trend, +653.7% $5.30B $5.25B $5.09B $2.08B $1.96B $1.68B $1.53B $1.30B $1.08B $928M $834M $704M
Shares Outstanding 6-point trend, +5.4% · · · · · · 99,825,080 98,573,354 96,657,881 95,929,916 95,319,722 94,705,743
Fluxo de Caixa 16
Dados anuais de Fluxo de Caixa para GMED
Métrica Tendência 202520242023202220212020201920182017201620152014
D&A 12-point trend, +1172.6% $277M $253M $146M $68M $70M $63M $53M $42M $42M $39M $24M $22M
Stock-based Comp 12-point trend, +600.0% $50M $54M $53M $33M $31M $27M $26M $22M $15M $11M $10M $7M
Deferred Tax 11-point trend, -3234.3% · $-134M $-58M $-22M $-18M $-4M $4M $971.0K $8M $-4M $6M $-4M
Amort. of Intangibles 12-point trend, +16500.3% $118M $119M $51M $18M $19M $17M $14M $10M $8M $3M $2M $712.0K
Restructuring · $30M · · · · · · · · · ·
Other Non-cash 11-point trend, -191.0% $-111M $243M $-19M · $44M $11M $-66M $-39M $-13M $22M $-31M $-38M
Operating Cash Flow 12-point trend, +851.7% $753M $521M $243M $178M $276M $199M $172M $182M $159M $148M $124M $79M
CapEx 12-point trend, +565.3% $165M $115M $78M $74M $57M $64M $71M $60M $51M $41M $51M $25M
Investing Cash Flow 12-point trend, -255.0% $-355M $-176M $303M $-110M $-376M $-117M $-140M $-193M $-111M $-163M $-153M $-100M
Stock Issued · · · · · · · · · · · $10M
Stock Repurchased 5-point trend, +187.0% $300M $86M $226M $144M · $105M · · · · · ·
Net Stock Activity 5-point trend, -3185.3% $-300M $-86M $-226M · · $-105M · · · · · $10M
Financing Cash Flow 12-point trend, -5346.1% $-679M $-28M $-232M $-110M $54M $-39M $24M $33M $2M $470.0K $4M $13M
Net Change in Cash 12-point trend, -3255.6% $-258M $317M $317M $-43M $-46M $44M $56M $21M $51M $-16M $-25M $-8M
Taxes Paid 8-point trend, +223.8% $99M $159M $101M $78M $45M $25M $34M $31M · · · ·
Free Cash Flow 11-point trend, +981.9% $589M $405M $165M · $219M $135M $101M $122M $108M $131M $71M $54M
Lucratividade 8
Dados anuais de Lucratividade para GMED
Métrica Tendência 202520242023202220212020201920182017201620152014
Gross Margin 9-point trend, -15.1% · · 65.0% · 75.0% 72.4% 77.1% 77.6% 76.3% 76.1% 75.6% 76.6%
Operating Margin 11-point trend, -44.0% 16.3% 6.6% 8.5% · 17.9% 14.1% 21.9% 23.8% 25.4% 27.3% 31.6% 29.2%
Net Margin 11-point trend, -6.2% 18.3% 4.1% 7.8% · 15.6% 13.0% 19.8% 21.9% 16.9% 18.5% 20.7% 19.5%
Pretax Margin 11-point trend, -29.6% 20.6% 4.8% 10.5% · 18.8% 16.0% 24.2% 26.5% 26.7% 27.9% 31.7% 29.2%
EBITDA Margin 11-point trend, -23.7% 25.8% 16.7% 17.7% · 25.2% 22.1% 28.6% 29.6% 32.1% 34.2% 36.0% 33.8%
ROA 11-point trend, -30.1% 10.2% 2.0% 3.4% · 8.2% 6.4% 11.0% 13.2% 10.7% 11.8% 14.7% 14.6%
ROE 11-point trend, -30.6% 12.1% 2.5% 3.0% · 8.6% 7.0% 11.3% 13.5% 11.9% 13.5% 17.3% 17.5%
ROIC 11-point trend, -40.8% 9.3% 3.4% 2.5% · 8.2% 6.0% 10.0% 11.8% 10.6% 12.3% 15.7% 15.8%
Liquidez e Solvência 2
Dados anuais de Liquidez e Solvência para GMED
Métrica Tendência 202520242023202220212020201920182017201620152014
Current Ratio 11-point trend, -18.9% 4.3 2.5 4.9 · 6.2 6.8 6.2 6.6 6.7 6.4 6.6 5.3
Quick Ratio 11-point trend, -27.1% 2.5 0.8 1.4 · 3.0 1.2 3.1 5.0 5.3 4.8 4.3 3.4
Eficiência 3
Dados anuais de Eficiência para GMED
Métrica Tendência 202520242023202220212020201920182017201620152014
Asset Turnover 11-point trend, -25.5% 0.6 0.5 0.4 · 0.5 0.5 0.6 0.6 0.6 0.6 0.7 0.7
Inventory Turnover 11-point trend, -1.8% 1.4 1.4 1.0 · 1.0 1.0 1.1 1.3 1.4 1.2 1.4 1.4
Receivables Turnover 11-point trend, -30.9% 4.8 4.7 4.4 · 6.3 5.3 5.4 5.6 6.1 6.6 7.1 6.9
Por Ação 5
Dados anuais de Por Ação para GMED
Métrica Tendência 202520242023202220212020201920182017201620152014
Book Value / Share 6-point trend, +127.3% · · · · · · $14.05 $12.03 $10.01 $8.67 $7.50 $6.18
Revenue / Share 11-point trend, +331.5% $21.44 $18.27 $13.68 · $9.25 $7.81 $7.70 $7.04 $6.50 $5.85 $5.67 $4.97
Cash Flow / Share 11-point trend, +562.8% $5.50 $3.78 $2.12 · $2.67 $1.97 $1.69 $1.79 $1.63 $1.78 $1.27 $0.83
Cash / Share 6-point trend, +125.4% · · · · · · $1.96 $1.42 $1.23 $1.38 $0.63 $0.87
EPS (TTM) 12-point trend, +304.1% $3.92 $0.75 $1.07 $1.85 $1.44 $1.01 $1.52 $1.54 $1.10 $1.08 $1.17 $0.97
Taxas de Crescimento 9
Dados anuais de Taxas de Crescimento para GMED
Métrica Tendência 202520242023202220212020201920182017201620152014
Revenue YoY 5-point trend, -22.3% 16.7% 60.6% 53.3% 6.8% 21.4% · · · · · · ·
Revenue CAGR 3Y 3-point trend, +63.8% 42.2% 38.0% 25.7% · · · · · · · · ·
Revenue CAGR 5Y 30.1% · · · · · · · · · · ·
EPS YoY 5-point trend, +892.9% 422.7% -29.9% -42.2% 28.5% 42.6% · · · · · · ·
EPS CAGR 3Y 3-point trend, +1366.0% 28.4% -19.5% 1.9% · · · · · · · · ·
EPS CAGR 5Y 31.2% · · · · · · · · · · ·
Net Income YoY 5-point trend, +820.8% 422.3% -16.2% -35.4% 27.5% 45.9% · · · · · · ·
Net Income CAGR 3Y 3-point trend, +557.5% 41.4% -11.6% 6.3% · · · · · · · · ·
Net Income CAGR 5Y 39.4% · · · · · · · · · · ·
Avaliação (TTM) 9
Dados anuais de Avaliação (TTM) para GMED
Métrica Tendência 202520242023202220212020201920182017201620152014
Revenue TTM 12-point trend, +519.5% $2.94B $2.52B $1.57B $1.02B $958M $789M $785M $713M $636M $564M $545M $474M
Net Income TTM 12-point trend, +481.6% $538M $103M $123M $190M $149M $102M $155M $156M $107M $104M $113M $92M
Market Cap 6-point trend, +161.1% · · · · · · $5.88B $4.27B $3.97B $2.38B $2.65B $2.25B
P/E 12-point trend, -9.1% 22.3 110.3 49.8 40.1 50.1 64.6 38.7 28.1 37.4 23.0 23.8 24.5
P/S 6-point trend, +57.7% · · · · · · 7.5 6.0 6.2 4.2 4.9 4.7
P/B 6-point trend, +9.0% · · · · · · 4.2 3.6 4.1 2.9 3.7 3.8
P / Cash Flow 6-point trend, +20.2% · · · · · · 34.2 23.5 24.9 13.8 21.7 28.4
P / FCF 6-point trend, +40.4% · · · · · · 58.1 35.0 36.7 18.2 37.2 41.4
Earnings Yield 12-point trend, +10.0% 4.5% 0.91% 2.0% 2.5% 2.0% 1.6% 2.6% 3.6% 2.7% 4.3% 4.2% 4.1%

Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos

Demonstração de Resultados
2025-12-312024-12-312023-12-312022-12-312021-12-31
Receita $2.94B$2.52B$1.57B$1.02B$958M
Margem Bruta % 65.0%75.0%
Margem Operacional % 16.3%6.6%8.5%17.9%
Lucro líquido $538M$103M$123M$190M$149M
EPS Diluído $3.92$0.75$1.07$1.85$1.44
Balanço Patrimonial
2025-12-312024-12-312023-12-312022-12-312021-12-31
Índice de liquidez corrente 4.32.54.96.2
Índice de Liquidez Seca 2.50.81.43.0
Fluxo de Caixa
2025-12-312024-12-312023-12-312022-12-312021-12-31
Fluxo de caixa livre $589M$405M$165M$219M

Sinais de trading Sinais recentes de compra/venda com preço de entrada e relação risco/recompensa

Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos

📊

Escolha as métricas que importam para você — clique no ➕ ao lado de qualquer linha em Fundamentos Completos acima.

Sua seleção é salva e acompanha você em todos os tickers.

Investidores institucionais (13F) 642 declarantes · $5.7B total · Em 30 de Junho de 2026

Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.

Atividade institucional — Q2 2026 vs trimestre anterior
Novas posições Posições encerradas Aumentou Diminuído Variação líquida de ações
82 (-34 vs trimestre anterior) 82 (+32 vs trimestre anterior) 241 (+21 vs trimestre anterior) 176 (-6 vs trimestre anterior) +453K

Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.

Instituição Valor Ações % de 13F rastreado Tipo
VANGUARD CAPITAL MANAGEMENT LLC $403.546.103 5.107.532 7,04% Ações
VANGUARD PORTFOLIO MANAGEMENT LLC $394.606.359 4.994.385 6,89% Ações
STATE STREET CORP $293.540.630 3.714.029 5,12% Ações
Sculptor Capital LP $237.030.000 3.000.000 4,14% Ações
Burgundy Asset Management Ltd. $212.054.428 3.460.983 3,70% Ações
ALLIANCEBERNSTEIN L.P. $205.090.439 2.380.344 3,58% Ações
DIMENSIONAL FUND ADVISORS LP $166.610.599 2.108.728 2,91% Ações
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $135.630.225 1.716.621 2,37% Ações
GEODE CAPITAL MANAGEMENT, LLC $134.690.079 1.704.191 2,35% Ações
Boston Partners $112.054.767 1.418.394 1,96% Ações
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC $101.519.633 1.284.896 1,77% Ações
Quantinno Capital Management LP $96.320.933 1.219.098 1,68% Ações
NORGES BANK $89.048.300 1.127.051 1,55% Ações
FULLER & THALER ASSET MANAGEMENT, INC. $88.055.393 1.114.484 1,54% Ações
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC $88.048.981 1.114.403 1,54% Ações
MANUFACTURERS LIFE INSURANCE COMPANY, THE $84.736.329 1.072.476 1,48% Ações
GENEVA CAPITAL MANAGEMENT LLC $78.941.870 999.138 1,38% Ações
Madison Avenue Partners, LP $73.891.416 935.216 1,29% Ações
Boston Trust Walden Corp $73.637.557 932.003 1,28% Ações
ANTIPODES PARTNERS Ltd $71.581.796 905.984 1,25% Ações
Global Alpha Capital Management Ltd. $67.681.230 856.616 1,18% Ações
Vestal Point Capital, LP $67.158.500 850.000 1,17% Ações
VANGUARD GROUP INC $59.221.500 678.290 1,03% Ações
Stephens Investment Management Group LLC $57.159.864 723.451 1,00% Ações
VANGUARD FIDUCIARY TRUST CO $56.575.822 716.059 0,99% Ações
Clark Capital Management Group, Inc. $54.271.890 686.899 0,95% Ações
AMERICAN CAPITAL MANAGEMENT INC $51.599.219 653.072 0,90% Ações
ANCHOR CAPITAL ADVISORS LLC $51.225.201 648.338 0,89% Ações
Camber Capital Management LP $47.216.000 800.000 0,82% Ações
Capital World Investors $46.664.254 590.612 0,81% Ações
Artemis Investment Management LLP $45.305.914 573.420 0,79% Ações
Swedbank AB $41.113.881 520.363 0,72% Ações
OBERWEIS ASSET MANAGEMENT INC/ $40.461.021 512.100 0,71% Ações
RAYMOND JAMES FINANCIAL INC $39.194.096 496.065 0,68% Ações
Paradice Investment Management LLC $39.023.513 493.906 0,68% Ações
Soleus Capital Management, L.P. $37.049.527 468.922 0,65% Ações
VICTORY CAPITAL MANAGEMENT INC $34.953.155 442.389 0,61% Ações
ENVESTNET ASSET MANAGEMENT INC $34.559.104 437.402 0,60% Ações
FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ $33.569.453 424.876 0,59% Ações
FIRST TRUST ADVISORS LP $32.942.568 416.943 0,57% Ações
FMR LLC $32.503.608 411.386 0,57% Ações
Grantham, Mayo, Van Otterloo & Co. LLC $32.370.792 409.705 0,56% Ações
Holocene Advisors, LP $31.598.627 399.932 0,55% Ações
Pembroke Management, LTD $31.513.929 398.860 0,55% Ações
GOLDMAN SACHS GROUP INC $31.286.538 395.982 0,55% Ações
Annex Advisory Services, LLC $30.189.344 350.387 0,53% Ações
Bares Capital Management, Inc. $29.845.058 521.129 0,52% Ações
Capital Impact Advisors, LLC $29.246.895 370.167 0,51% Ações
SIRIOS CAPITAL MANAGEMENT L P $28.050.051 355.019 0,49% Ações
Bridgewater Associates, LP $27.809.466 351.974 0,49% Ações
CONGRESS ASSET MANAGEMENT CO $26.754.761 338.625 0,47% Ações
Terril Brothers, Inc. $25.403.295 321.520 0,44% Ações
Sio Capital Management, LLC $23.846.482 301.816 0,42% Ações
SEGALL BRYANT & HAMILL, LLC $23.729.389 300.334 0,41% Ações
Champlain Investment Partners, LLC $22.982.271 290.878 0,40% Ações
RHUMBLINE ADVISERS $22.513.223 284.942 0,39% Ações
Gotham Asset Management, LLC $22.364.413 283.058 0,39% Ações
UBS Group AG $22.286.430 282.071 0,39% Ações
KENNEDY CAPITAL MANAGEMENT LLC $22.020.640 278.707 0,38% Ações
MetLife Investment Management, LLC $21.771.680 275.556 0,38% Ações
Kathmere Capital Management, LLC $21.450.978 271.497 0,37% Ações
Retirement Systems of Alabama $20.830.354 263.642 0,36% Ações
Foresight Group Ltd Liability Partnership $19.759.724 254.030 0,34% Ações
NICHOLAS COMPANY, INC. $19.699.484 249.329 0,34% Ações
BANK OF AMERICA CORP /DE/ $19.524.872 247.119 0,34% Ações
Varenne Capital Partners $18.807.009 238.200 0,33% Ações
GLENMEDE TRUST CO NA $18.639.881 235.918 0,33% Ações
Mesirow Institutional Investment Management, Inc. $18.549.041 224.266 0,32% Ações
California Public Employees Retirement System $18.120.944 229.350 0,32% Ações
Woodline Partners LP $17.906.826 226.640 0,31% Ações
Swiss National Bank $17.862.344 226.077 0,31% Ações
Corient Private Wealth LP $17.322.828 219.248 0,30% Ações
GABELLI FUNDS LLC $16.671.110 211.000 0,29% Ações
Lightrock Netherlands B.V. $16.367.000 207.151 0,29% Ações
Sofinnova Investments, Inc. $15.802.000 200.000 0,28% Opção de compra
RENAISSANCE TECHNOLOGIES LLC $15.558.491 196.918 0,27% Ações
STATE OF WISCONSIN INVESTMENT BOARD $15.455.225 195.611 0,27% Ações
LPL Financial LLC $15.233.500 192.805 0,27% Ações
Susquehanna Portfolio Strategies, LLC $15.165.574 191.945 0,26% Ações
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ $14.032.018 177.598 0,24% Ações
Leith Wheeler Investment Counsel Ltd. $13.821.540 174.934 0,24% Ações
BlackRock, Inc. $13.638.706 172.620 0,24% Ações
AMERICAN CENTURY COMPANIES INC $13.486.770 170.697 0,24% Ações
WCM INVESTMENT MANAGEMENT, LLC $13.455.918 160.304 0,23% Ações
Leeward Investments, LLC - MA $12.983.476 164.327 0,23% Ações
Walleye Capital LLC $12.358.823 156.421 0,22% Ações
JANUS HENDERSON GROUP PLC $12.232.394 141.973 0,21% Ações
Bellevue Group AG $11.543.993 146.108 0,20% Ações
Sterling Investment Advisors, Ltd. $11.379.257 144.023 0,20% Ações
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM $11.223.202 130.260 0,20% Ações
Defilade Capital Management, L.P. $11.032.719 139.637 0,19% Ações
PARADIGM CAPITAL MANAGEMENT INC/NY $10.934.984 138.400 0,19% Ações
Glenmede Investment Management, LP $10.909.935 190.500 0,19% Ações
BNP PARIBAS FINANCIAL MARKETS $10.809.042 136.806 0,19% Ações
ALGERT GLOBAL LLC $10.560.477 133.660 0,18% Ações
GAMCO INVESTORS, INC. ET AL $10.209.435 129.217 0,18% Ações
ArrowMark Colorado Holdings LLC $9.102.268 115.204 0,16% Ações
STRS OHIO $8.815.936 111.580 0,15% Ações
VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. $8.503.609 107.627 0,15% Ações
VANGUARD ASSET MANAGEMENT, Ltd $8.430.130 106.697 0,15% Ações

Executivos da empresa 22 insiders · 11 diretores · 15 conselheiros

Investidor com informação privilegiada Função Última atividade Ações detidas Compras 12m Vendas 12m Líquido 12m
Keith W Pfeil President, CEO 21 de Janeiro de 2026 A 0 0 0 $0
Daniel T Scavilla President, CEO 23 de Janeiro de 2025 A 0 0 0 $0
David M Demski President, CEO 27 de Janeiro de 2022 A 0 0 0 $0
Kyle Kline Senior Vice President, CFO 21 de Janeiro de 2026 A 0 0 2 $-2.032.133
Richard A Baron Senior VP and CFO 2 de Maio de 2014 M 0 0 0 $0
Anthony L Williams President 7 de Março de 2019 M 0 0 0 $0
Kelly Huller EVP, GC, Corporate Secretary 25 de Fevereiro de 2026 M 0 0 3 $-3.441.700
David C Paul Executive Chairman 21 de Janeiro de 2026 A 60.417 0 0 $0
Steven Payne Chief Accounting Officer 1 de Fevereiro de 2019 A 0 0 0 $0
Eric Schwartz Senior VP and General Counsel 25 de Junho de 2018 M 0 0 0 $0
Brett A Murphy EVP, International Sales 2 de Fevereiro de 2018 A 35.217 0 0 $0
David D Davidar Conselheiro 27 de Julho de 2026 G 507.675 0 2 $-4.169.000
Ann D Rhoads Conselheiro 4 de Junho de 2026 M 40.384 0 3 $-1.402.600
Dan Wolterman Conselheiro 21 de Janeiro de 2026 A 24.025 0 0 $0
Leslie V Norwalk Conselheiro 21 de Janeiro de 2026 A 10.419 0 2 $-557.600
Dan Lemaitre Conselheiro 21 de Janeiro de 2026 A 0 0 0 $0
John A Deford Conselheiro 21 de Janeiro de 2026 A 15.578 0 0 $0
Robert Andrew Douglas Conselheiro 21 de Janeiro de 2026 A 2.005 0 0 $0
Stephen T Zarrilli Conselheiro 21 de Janeiro de 2026 A 0 0 1 $-2.107.250
James R Tobin Conselheiro 21 de Janeiro de 2026 A 0 0 0 $0
Kurt Wheeler Conselheiro 22 de Janeiro de 2019 A 44.319 0 0 $0
Robert Liptak Conselheiro 22 de Janeiro de 2019 A 26.159 0 0 $0

Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto

Participação em ETFs Detido por 99 ETFs

O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.

Fundo Peso Unidades Em Fonte
FXH · First Trust Exchange-Traded AlphaDE… 2,27% 219.621 NS 30 de Abril de 2026 N-PORT
HTEC · EXCHANGE TRADED CONCEPTS TRUST 1,86% 10.979 NS 30 de Abril de 2026 N-PORT
BUL · Pacer Funds Trust 1,53% 21.591 NS 30 de Abril de 2026 N-PORT
LFSC · RBB Fund, Inc. 1,27% 16.258 NS 31 de Maio de 2026 N-PORT
ROBO · EXCHANGE TRADED CONCEPTS TRUST 1,24% 242.837 NS 30 de Abril de 2026 N-PORT
DTEC · ALPS ETF Trust 0,87% 7.891 NS 31 de Maio de 2026 N-PORT
TAX · EA Series Trust 0,86% 2.682 NS 29 de Maio de 2026 N-PORT
LSEQ · Harbor ETF Trust 0,83% 1.408 NS 30 de Abril de 2026 N-PORT
MCOW · Pacer Funds Trust 0,82% 90 NS 30 de Abril de 2026 N-PORT
FNY · First Trust Exchange-Traded AlphaDE… 0,55% 31.832 NS 30 de Abril de 2026 N-PORT
TMFX · RBB Fund, Inc. 0,54% 2.130 NS 31 de Maio de 2026 N-PORT
MMSC · First Trust Exchange-Traded Fund VI… 0,39% 2.462 NS 31 de Maio de 2026 N-PORT
JPME · J.P. Morgan Exchange-Traded Fund Tr… 0,38% 18.545 NS 30 de Abril de 2026 N-PORT
GQQQ · EA Series Trust 0,34% 5.950 NS 29 de Maio de 2026 N-PORT
BKMC · BNY Mellon ETF Trust 0,31% 21.679 NS 30 de Abril de 2026 N-PORT
PTMC · Pacer Funds Trust 0,29% 12.781 NS 30 de Abril de 2026 N-PORT
FNX · First Trust Exchange-Traded AlphaDE… 0,29% 42.239 NS 30 de Abril de 2026 N-PORT
SMDX · Tidal Trust III 0,29% 3.969 NS 30 de Abril de 2026 N-PORT
MSSM · MORGAN STANLEY PATHWAY FUNDS 0,28% 26.195 NS 31 de Maio de 2026 N-PORT
ANEW · ProShares Trust 0,26% 244 NS 31 de Maio de 2026 N-PORT
CLSE · Trust for Professional Managers 0,23% 17.617 NS 31 de Maio de 2026 N-PORT
BFOR · ALPS ETF Trust 0,22% 5.809 NS 31 de Maio de 2026 N-PORT
FSMD · FIDELITY COVINGTON TRUST 0,21% 56.008 NS 30 de Abril de 2026 N-PORT
BBMC · J.P. Morgan Exchange-Traded Fund Tr… 0,21% 46.648 NS 30 de Abril de 2026 N-PORT
MIDU · Direxion Shares ETF Trust 0,20% 1.845 NS 30 de Abril de 2026 N-PORT
MVV · ProShares Trust 0,20% 3.849 NS 31 de Maio de 2026 N-PORT
SCHA · SCHWAB STRATEGIC TRUST 0,19% 535.955 NS 31 de Maio de 2026 N-PORT
AFSM · First Trust Exchange-Traded Fund VI… 0,17% 2.091 NS 31 de Maio de 2026 N-PORT
SCHM · SCHWAB STRATEGIC TRUST 0,17% 300.905 NS 31 de Maio de 2026 N-PORT
FAD · First Trust Exchange-Traded AlphaDE… 0,16% 8.751 NS 30 de Abril de 2026 N-PORT
FHLC · FIDELITY COVINGTON TRUST 0,16% 51.771 NS 30 de Abril de 2026 N-PORT
JPUS · J.P. Morgan Exchange-Traded Fund Tr… 0,16% 7.980 NS 30 de Abril de 2026 N-PORT
REVS · Columbia ETF Trust I 0,15% 4.563 NS 30 de Abril de 2026 N-PORT
UMDD · ProShares Trust 0,14% 538 NS 31 de Maio de 2026 N-PORT
DFAS · Dimensional ETF Trust 0,13% 199.853 NS 30 de Abril de 2026 N-PORT
FNDA · SCHWAB STRATEGIC TRUST 0,12% 130.279 NS 31 de Maio de 2026 N-PORT
AVMC · AMERICAN CENTURY ETF TRUST 0,11% 5.689 NS 31 de Maio de 2026 N-PORT
DFSV · Dimensional ETF Trust 0,11% 93.762 NS 30 de Abril de 2026 N-PORT
GINN · Goldman Sachs ETF Trust 0,10% 2.587 NS 31 de Maio de 2026 N-PORT
RECS · Columbia ETF Trust I 0,08% 46.018 NS 30 de Abril de 2026 N-PORT
DFAT · Dimensional ETF Trust 0,06% 90.797 NS 30 de Abril de 2026 N-PORT
DFUV · Dimensional ETF Trust 0,05% 87.253 NS 30 de Abril de 2026 N-PORT
DEUS · DBX ETF Trust 0,05% 1.713 NS 29 de Maio de 2026 N-PORT
DFAC · Dimensional ETF Trust 0,04% 188.153 NS 30 de Abril de 2026 N-PORT
DFSU · Dimensional ETF Trust 0,03% 7.802 NS 30 de Abril de 2026 N-PORT
DXUV · Dimensional ETF Trust 0,03% 1.238 NS 30 de Abril de 2026 N-PORT
GVUS · Goldman Sachs ETF Trust 0,03% 1.350 NS 31 de Maio de 2026 N-PORT
AVLC · AMERICAN CENTURY ETF TRUST 0,02% 3.743 NS 31 de Maio de 2026 N-PORT
AVUS · AMERICAN CENTURY ETF TRUST 0,02% 36.715 NS 31 de Maio de 2026 N-PORT
DCOR · Dimensional ETF Trust 0,02% 6.939 NS 30 de Abril de 2026 N-PORT